<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title><![CDATA[EC21 Product Catalogs - wes]]></title>
<link><![CDATA[https://www.ec21.com/ec-market/wes--212514/1/wes.html]]></link><item>
<title><![CDATA[Clinical WES]]></title><link><![CDATA[https://capitalbio.en.ec21.com/Clinical_WES--11689438_11689447.html]]></link><description><![CDATA[WES
The Clinical WES test of CapitalBio Technology is based on the BES4000 semiconductor sequencing platform, uses target region capture and the NGS technology to detect all exonic regions and more t]]></description><pubDate><![CDATA[20221209]]></pubDate></item>

</channel>
</rss>